Literature DB >> 34816407

Development and Evaluation of DNA Vaccine Against Salmonid Alphavirus.

Chia-Jung Chang1.   

Abstract

Despite vaccination, pancreas disease (PD) caused by salmonid alphavirus (SAV) has been the economically most important virus disease in salmon farming in Ireland, Scotland, and Norway. A vaccine based on DNA plasmid has been authorized to be used in Norwegian aquaculture since 2018. DNA vaccination of plasmids expressed subcellular viral proteins have been shown its particular protective effect against SAV3 that surface expression of the E2 protein with the whole viral protein construct, yielding a more effective vaccine. The chapter describes methods to design and test the sublocalization of expressed viral protein and the performance evaluation of vaccines against SAV3 infection in Atlantic salmon.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  DNA vaccine; ELISA; Histopathology; Neutralizing activity; Pancreas disease; Salmonid alphavirus; Subcellular antigen expression

Mesh:

Substances:

Year:  2022        PMID: 34816407     DOI: 10.1007/978-1-0716-1888-2_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Protective effect and antibody response of DNA vaccine against salmonid alphavirus 3 (SAV3) in Atlantic salmon.

Authors:  C J Chang; J Gu; B Robertsen
Journal:  J Fish Dis       Date:  2017-05-11       Impact factor: 2.767

2.  Salmonid alphavirus glycoprotein E2 requires low temperature and E1 for virion formation and induction of protective immunity.

Authors:  Mia C Hikke; Stine Braaen; Stephane Villoing; Kjartan Hodneland; Corinne Geertsema; Lisa Verhagen; Petter Frost; Just M Vlak; Espen Rimstad; Gorben P Pijlman
Journal:  Vaccine       Date:  2014-09-27       Impact factor: 3.641

Review 3.  Alphavirus infections in salmonids--a review.

Authors:  M F McLoughlin; D A Graham
Journal:  J Fish Dis       Date:  2007-09       Impact factor: 2.767

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.